15-43599215-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001375484.1(CKMT1B):c.1196G>A(p.Arg399His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00688 in 1,613,626 control chromosomes in the GnomAD database, including 191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0059 ( 17 hom., cov: 30)
Exomes 𝑓: 0.0070 ( 174 hom. )
Consequence
CKMT1B
NM_001375484.1 missense
NM_001375484.1 missense
Scores
1
5
8
Clinical Significance
Conservation
PhyloP100: 2.52
Publications
7 publications found
Genes affected
CKMT1B (HGNC:1995): (creatine kinase, mitochondrial 1B) Mitochondrial creatine (MtCK) kinase is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Many malignant cancers with poor prognosis have shown overexpression of ubiquitous mitochondrial creatine kinase; this may be related to high energy turnover and failure to eliminate cancer cells via apoptosis. Ubiquitous mitochondrial creatine kinase has 80% homology with the coding exons of sarcomeric mitochondrial creatine kinase. Two genes located near each other on chromosome 15 have been identified which encode identical mitochondrial creatine kinase proteins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012996405).
BP6
Variant 15-43599215-G-A is Benign according to our data. Variant chr15-43599215-G-A is described in ClinVar as [Benign]. Clinvar id is 778548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00589 (895/151904) while in subpopulation SAS AF = 0.0219 (105/4802). AF 95% confidence interval is 0.0185. There are 17 homozygotes in GnomAd4. There are 445 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CKMT1B | NM_001375484.1 | c.1196G>A | p.Arg399His | missense_variant | Exon 9 of 9 | ENST00000441322.6 | NP_001362413.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00581 AC: 882AN: 151788Hom.: 15 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
882
AN:
151788
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00623 AC: 1567AN: 251408 AF XY: 0.00729 show subpopulations
GnomAD2 exomes
AF:
AC:
1567
AN:
251408
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00698 AC: 10209AN: 1461722Hom.: 174 Cov.: 32 AF XY: 0.00747 AC XY: 5434AN XY: 727166 show subpopulations
GnomAD4 exome
AF:
AC:
10209
AN:
1461722
Hom.:
Cov.:
32
AF XY:
AC XY:
5434
AN XY:
727166
show subpopulations
African (AFR)
AF:
AC:
132
AN:
33478
American (AMR)
AF:
AC:
128
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
28
AN:
26132
East Asian (EAS)
AF:
AC:
1
AN:
39692
South Asian (SAS)
AF:
AC:
1641
AN:
86248
European-Finnish (FIN)
AF:
AC:
34
AN:
53408
Middle Eastern (MID)
AF:
AC:
61
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
7789
AN:
1111894
Other (OTH)
AF:
AC:
395
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
596
1192
1787
2383
2979
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00589 AC: 895AN: 151904Hom.: 17 Cov.: 30 AF XY: 0.00599 AC XY: 445AN XY: 74266 show subpopulations
GnomAD4 genome
AF:
AC:
895
AN:
151904
Hom.:
Cov.:
30
AF XY:
AC XY:
445
AN XY:
74266
show subpopulations
African (AFR)
AF:
AC:
209
AN:
41394
American (AMR)
AF:
AC:
68
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
6
AN:
3462
East Asian (EAS)
AF:
AC:
1
AN:
5166
South Asian (SAS)
AF:
AC:
105
AN:
4802
European-Finnish (FIN)
AF:
AC:
3
AN:
10564
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
480
AN:
67930
Other (OTH)
AF:
AC:
7
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
18
ESP6500EA
AF:
AC:
61
ExAC
AF:
AC:
816
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 02, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.